Company Valuation: AB Science

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 332.2 180.9 57.55 112 56.25 - -
Change - -45.55% -68.19% 94.7% -49.8% - -
Enterprise Value (EV) 332.2 180.9 57.55 112 56.25 56.25 56.25
Change - -45.55% -68.19% 94.7% -49.8% 0% 0%
P/E -24.4x -17.8x -5.88x - - - -
PBR - - - - - - -
PEG - 0.6x 0.2x - - - -
Capitalization / Revenue - 187x 53.7x 95.4x 46.9x 43.3x 35.2x
EV / Revenue - 0x 0x 0x 46.9x 43.3x 35.2x
EV / EBITDA - - - - - - -
EV / EBIT - -0x -0x 0x -8.65x -8.79x -
EV / FCF - -0x - -0x -8.79x -15.6x -14.4x
FCF Yield - -9.52% - -4.08% -11.4% -6.4% -6.93%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -0.29 -0.2 -0.15 - - - -
Distribution rate - - - - - - -
Net sales 1 - 0.97 1.072 1.174 1.2 1.3 1.6
EBITDA - -11.16 -5.416 - - - -
EBIT 1 - -13.43 -6.083 0.639 -6.5 -6.4 -
Net income -13.62 -10.05 -7.831 - - - -
Net Debt - - - - - - -
Reference price 2 7.0900 3.5550 0.8820 1.5360 0.7030 0.7030 0.7030
Nbr of stocks (in thousands) 46,861 50,891 65,248 72,947 80,015 - -
Announcement Date 01/03/23 15/05/24 13/05/25 13/05/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
108.04x6.02x25.53x2.3% 37TCr
23.54x3.2x11.19x1.68% 7.08TCr
14.62x7.18x11x - 1.2TCr
17x2.19x7.45x2.61% 871.75Cr
20.89x6.55x17.44x-.--% 500.03Cr
42.63x2.67x30.49x0.67% 459.34Cr
36.37x5.67x16.61x - 316.11Cr
-218.65x - - -.--% 254.19Cr
Average 5.55x 4.78x 17.10x 1.21% 5.91TCr
Weighted average by Cap. 87.56x 5.52x 22.57x 2.16%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA